Related Experiment Videos
Late relapses in Hodgkin disease
American Journal of Hematology
|January 1, 1981
Summary
Late relapse of Hodgkin disease (HD) after 3 years in complete remission (CR) is uncommon. Patients experiencing late relapse showed a trend towards superior survival post-salvage therapy compared to early relapsers.
Area of Science:
- Oncology
- Hematology
- Clinical Medicine
Background:
- Hodgkin disease (HD) is a cancer of the lymphatic system.
- Complete remission (CR) is a key treatment goal for HD patients.
- Understanding relapse patterns is crucial for long-term patient management.
Purpose of the Study:
- To investigate the characteristics and outcomes of patients with late relapse of Hodgkin disease.
- To compare the survival of late relapsers with early relapsers after salvage therapy.
Main Methods:
- Retrospective analysis of a cohort of 142 Hodgkin disease patients.
- Definition of late relapse as occurring at least 3 years after initial therapy.
- Comparison of actuarial survival between late and early relapse groups using Gehan's method.
Main Results:
- Eight out of 84 patients in CR for over 3 years experienced a late relapse (median disease-free interval of 53 months).
- Six late relapses involved dissemination.
- All late relapsing patients were successfully salvaged and achieved CR.
- A trend towards superior actuarial survival in late relapsers compared to early relapsers was observed (P=0.07).
Conclusions:
- Late relapse of Hodgkin disease is a distinct pattern of recurrence.
- Patients with late relapse demonstrate favorable outcomes after salvage therapy.
- Further research is warranted to confirm the statistical significance of improved survival in late relapsers.